Navigation Links
Buckfire & Buckfire, P.C. Dangerous Drug Lawyers Now Accepting Michigan Actos Lawsuits
Date:6/10/2013

Southfield, MI (PRWEB) June 11, 2013

The dangerous drug legal team at the personal injury law firm of Buckfire & Buckfire, P.C. is now actively accepting Actos lawsuits for those patients allegedly suffering serious injuries after taking the prescribed diabetes drug. The dangerous drug lawyers are accepting all cases that involve patients who have been diagnosed with bladder cancer while taking Actos or within five years of their Actos usage.

Actos, also known as a pioglitazone, is a drug that is prescribed for treatment of diabetes, particularly Type 2 diabetes. However, even though Actos is known to be an effective drug in treating this medical condition, the drug has also been allegedly linked to bladder cancer. In fact, on June 15, 2011 the FDA have warned patients that the drug Actos may be associated with developing bladder cancer. (Click here to view the FDA Drug Safety Communication report on Actos).

Patients allegedly suffering from bladder after taking the drug Actos do have legal rights and may have a possible Actos lawsuit against the drug manufacturer, Takeda Pharmaceutical. These cases seek fair compensation to patients who have been allegedly harmed by the medication that was prescribed to them by their physicians.

“There are strict statute of limitations for filing a Michigan Actos lawsuit. If you miss a deadline your case will be lost forever. It is important when choosing your lawyer for your bladder cancer Actos case that you choose an attorney that has significant experience in dangerous drug cases and representing patients injured or harmed by a dangerous drug. At the law firm of Buckfire & Buckfire, P.C. our Michigan Actos lawyers work directly with other national law firms to win the best settlement for our clients,” says Partner and Attorney Lawrence J. Buckfire.

Patients taking Actos and their physicians should be fully aware of the alleged potential association between Actos and bladder cancer, as well as other side effects of the drug.

ABOUT BUCKFIRE & BUCKFIRE, P.C.

Buckfire & Buckfire, P.C. is a family-owned Michigan personal injury law firm representing patients who have been diagnosed with bladder cancer or allegedly suffering from bladder cancer during their Actos diabetes drug usage. Patients harmed do have legal rights and there may be legal ground to pursue a lawsuit. The Michigan Actos lawyers at the award winning law firm offers a free no obligation consultation and has a No Win No Fee guarantee, meaning there are no legal fees or costs until your case is settled or won.

To learn more about the Michigan Actos lawyers at Buckfire & Buckfire, P.C. call toll-free at (800) 606-1717 or visit the law firm website at http://www.BuckfireLaw.com

To view a recent video by the Buckfire & Buckfire, P.C. law firm on their active representation of Actos lawsuits visit http://youtu.be/B9gcYFzcfDg

Read the full story at http://www.prweb.com/releases/2013/6/prweb10813883.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Buckfire & Buckfire, P.C. Accident Attorneys Announce New Ugly Christmas Sweater Social Media Contest
2. Slip and Fall Accident Attorney At Buckfire & Buckfire, P.C. Makes Michigan Lawyers Weekly For Fall on Ice Settlement
3. Buckfire & Buckfire Motorcycle Attorney Meets with Legislators on Issues Affecting Injured Motorcyclists
4. Michigan Car Accident Attorneys at Buckfire & Buckfire, P.C. Sponsor Gala for Spinal Cord Injury Victims
5. Michigan Bike Accident Lawyers at Buckfire & Buckfire Celebrate Bicycle Helmet Safety Week
6. Michigan Car Accident Lawyer at Buckfire & Buckfire, P.C. Creates Drunk Driving Deaths Infographic
7. Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week
8. Buckfire & Buckfire, P.C. Michigan Hip Replacement Lawyers Now Accepting Stryker Hip Implant Lawsuits
9. Buckfire & Buckfire, P.C. Lawyers Now Accepting Michigan Mirena IUD Lawsuits
10. Research shows efficacy of treatment model developed at Women & Infants
11. Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... ... 28, 2017 , ... Bill Howe started his sewer and drain company in ... Howe joined the team, the Bill Howe brand was born and they began cultivating ... giving back to the San Diego community in which they worked, lived and were ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a leading ... Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, a ... of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and Vitamin ...
(Date:4/27/2017)... ... April 27, 2017 , ... Today, Jefferson Health in Philadelphia ... announced an agreement to create the Jane and Leonard Korman Respiratory Institute in ... Leonard Korman Family Foundation. The collaboration leverages the strengths of each organization and ...
(Date:4/27/2017)... ... 27, 2017 , ... Last night, Christine Collins of New ... for her extraordinary compassion and lifelong dedication to serve others. Since 1997, Home ... the prestigious award each year – identifying a CAREGiver who has exemplified exceptional ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology: